Triaxiphin 1 g, 250 mg, 500 mg Injection
PDF Leaflet Revision Date: 06 December 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various bacterial infections.
Dosage (summary)
Adults: 1-2 g once daily; severe cases: up to 4 g once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; crosses placenta and excreted in breast milk.
Key Drug Interactions
- Calcium-containing products
- Aminoglycosides
- Vitamin K antagonists
Contraindications
- Hypersensitivity to ceftriaxone
- Premature neonates
- Hyperbilirubinemic newborns
Common side effects
- Eosinophilia
- Leucopenia
- Thrombocytopenia
- Diarrhoea
- Rash
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with calcium solutions
- Report any unusual symptoms
Serious warnings
- Serious hypersensitivity reactions
- Clostridium difficile associated diarrhoea
- Risk of ceftriaxone-calcium precipitation
Important Disclaimer
The Triaxiphin 1 g, 250 mg, 500 mg Injection professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
